Parker Conrad — May 11, 2022 Rippling has raised $250M in a round co-led by Bedrock and Kleiner Perkins, with participation from existing investors Y Combinator, Sequoia Capital, and more. The round values the company at $11.25 billion. I’m grateful for these investors’ conviction in Rippling, for the employees that have gotten us to this point,[…]
PreIPOSwap.com New York, NY – 5/8/2022 — Markets have been unhinged to say the least. Many are asking us how to hedge the controlled demolition of the US Dollar – other than the obvious Silver and Gold. The answer is in hard commodities as well as tools that can make commodities, such as factories. Another[…]
By Niloofer Shaikh, HilleVax (HLVX) has priced its upsized initial public offering of 11.765M shares of common stock at $17.00 per share, for gross proceeds of approximately $200M. The offering was upsized from $10.3M shares to 11.765M shares and priced within the estimated range of $16 and $18 per share. The shares are expected to begin trading on[…]
By Val kennedy, Norovirus vaccine developer HilleVax (HLVX) shares rose 10% following its upsized $200M initial public offering. Shares of HLVX opened at $18.76 after pricing at $17 per share. The stock recently changed hands at $18.70, up 10%, at approximately 12:00 p.m. ET. HLVX offered approximately 11.8M shares priced at $17 per share, raising[…]
By Renaissance Capital, Magic Empire Global Limited, a Hong Kong-based provider of financial advisory and underwriting services, filed on Friday with the SEC to raise up to $23 million in an initial public offering. The company plans to raise $23 million by offering 5 million shares at a price range of $4 to $5. At[…]
By Renaissance Capital, Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The Bellevue, WA-based company plans to raise $60 million by offering 6 million units at $10. Each unit[…]
By Renaissance Capital, In what would be the second largest IPO of the year, eyecare company Bausch + Lomb (BLCO) is scheduled to debut in the week ahead. Some small issuers and SPACs may also price during the week. Planning to dual list on the NYSE and the TSX, Bausch Health spin-off Bausch + Lomb (BLCO) is expected to[…]